XinXing Wang. Advances and Therapeutic Strategies in Targeted Delivery of Traditional Chinese Medicine for Drug-Induced Liver Injury. 2026. biomedRxiv.202601.00026
Advances and Therapeutic Strategies in Targeted Delivery of Traditional Chinese Medicine for Drug-Induced Liver Injury
Corresponding author: XinXing Wang, wxxemail@sina.cn
DOI: 10.12201/bmr.202601.00026
-
Abstract: Drug-induced liver injury (DILI) is a leading cause of acute liver failure. Current Western medical treatment primarily relies on drug discontinuation and supportive therapy, lacking efficient broad-spectrum detoxification agents, while the efficacy of N-acetylcysteine is significantly time-limited. Traditional Chinese medicine (TCM) demonstrates therapeutic potential through multi-target regulation, but its clinical translation is severely constrained by the complexity of its components and the risk of hepatotoxicity. In response to these challenges, this article systematically reviews recent advances in targeted delivery technologies: engineered modifications of nanocarriers enhance selective drug accumulation in the liver; the design of microenvironment-responsive drug release systems enables precise controlled release at the lesion site; and the use of extracellular vesicles (EVs) leverages their innate targeting capability and low immunogenicity to reduce systemic exposure risks. These strategies provide crucial technical support and a translational pathway for the effective and safe application of TCM in the treatment of DILI.
Key words: Drug-induced liver injury; Traditional Chinese medicine; Targeted delivery technologySubmit time: 9 January 2026
Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity. -
图表
-
Zhulei. Research Progress on Drug-induced Liver Injury with Immune Characteristics. 2025. doi: 10.12201/bmr.202504.00001
ZhangJinmei, HuDandan. Paxlovid causing delayed drug-induced liver damage in a case and literature analysis. 2025. doi: 10.12201/bmr.202502.00033
Zhu Xiaojing. . 2024. doi: 10.12201/bmr.202412.00015
xieping. The Traditional Chinese Medicine Syndrome Differentiation and Treatment for Radiation-induced Vaginal Injury Based on Theory of Evil Hidden in Moyuan. 2025. doi: 10.12201/bmr.202511.00016
wangminggang, luojuan, mozhengyuan, chenxinxin, wangxiufeng. The Role of Immune Cells and Traditional Chinese Medicine in Acute-on-Chronic Liver Failure. 2025. doi: 10.12201/bmr.202504.00030
刘永珍, Wang ling, Liu Fu Ron. Medication patterns of traditional Chinese medicine in the treatment of radiotherapy-induced oral mucositis:A study based on data mining. 2025. doi: 10.12201/bmr.202504.00049
fangjie, zhangaili. Research Advances in Clinical Treatment of Psoriasis: From Traditional Drugs to Biological Agents and Emerging Strategies. 2025. doi: 10.12201/bmr.202512.00051
Research Progress on the Application of Traditional Chinese Medicine in Bowel Preparation Before Colonoscopy. 2026. doi: 10.12201/bmr.202601.00054
lvshuzhen. Study on the Factors Influencing Patients Willingness to Use Chinese Medicine Delivery Service Based on Hospital WeChat Public Platform. 2022. doi: 10.12201/bmr.202209.00010
Li Lingbing, Chen Xi. The Research Progress of Traditional Chinese Medicine Monomers in Precancerous Lesions of Gastric Cancer. 2025. doi: 10.12201/bmr.202511.00037
-
ID Submit time Number Download 1 2025-11-04 10.12201/bmr.202601.00026V1
Download -
-
Public Anonymous To author only
Get Citation
Article Metrics
- Read: 115
- Download: 0
- Comment: 0

Login
Register




京公网安备